www.fdanews.com/articles/209253-baxter-international-gets-510k-clearance-for-novum-iq-syringe-infusion-pump
Baxter International Gets 510(k) Clearance for Novum IQ Syringe Infusion Pump
September 2, 2022
Baxter International’s Novum IQ syringe infusion pump and Dose IQ safety software have received 510(k) clearance from the FDA for pediatric or neonatal use.
The Novum IQ pump delivers small amounts of fluid at low rates in pediatric, neonatal or anesthesia care settings. The Dose IQ software links the syringe infusion pump with a web-based drug library and dose error reduction system.
The infusion pump can also be integrated with hospital electronic medical records through the company’s IQ Enterprise connectivity suite.
Baxter’s 510(k) application for its large volume Novum IQ pump is still pending.